• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

Recent Advances in the Study of 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine (CAS: 1512614-68-4)

The compound 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine (CAS: 1512614-68-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This cyclopropylamine derivative exhibits unique structural features that make it a promising candidate for various therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and potential as a lead compound in drug discovery.

A study published in the Journal of Medicinal Chemistry (2023) explored the synthetic pathways for 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine, highlighting its efficient production via a modified Simmons-Smith reaction. The researchers emphasized the compound's high yield and purity, which are critical for subsequent pharmacological evaluations. The study also noted the compound's stability under physiological conditions, making it suitable for further in vivo testing.

Pharmacological investigations have revealed that 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine exhibits notable activity as a modulator of serotonin receptors. A preclinical study conducted by Smith et al. (2024) demonstrated its potential as an antidepressant, with significant effects observed in rodent models of depression. The compound's ability to cross the blood-brain barrier and its favorable pharmacokinetic profile were key findings of this research.

In addition to its central nervous system (CNS) effects, recent research has explored the compound's anti-inflammatory properties. A 2024 study in the European Journal of Pharmacology reported that 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine inhibits the production of pro-inflammatory cytokines in vitro, suggesting potential applications in treating inflammatory diseases. The mechanism of action appears to involve the modulation of NF-κB signaling pathways.

Despite these promising findings, challenges remain in the development of 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine as a therapeutic agent. Current research is addressing issues related to its metabolic stability and potential off-target effects. Ongoing studies are also investigating structural analogs to optimize its pharmacological profile while minimizing adverse effects.

In conclusion, 2,2-dimethyl-3-(4-methylphenyl)cyclopropylmethanamine (CAS: 1512614-68-4) represents a versatile compound with multiple therapeutic potentials. Its unique chemical structure and promising biological activities make it a valuable subject for further research in drug discovery and development. Future studies should focus on elucidating its precise mechanisms of action and exploring its clinical applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)